{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:14:02Z","timestamp":1791274442320,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.nano.2013.07.011","type":"journal-article","created":{"date-parts":[[2013,7,25]],"date-time":"2013-07-25T03:23:47Z","timestamp":1374722627000},"page":"167-176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":174,"title":["Biotinylated liposomes as potential carriers for the oral delivery of insulin"],"prefix":"10.1016","volume":"10","author":[{"given":"Xingwang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2013.07.011_bb0005","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0169-409X(98)00075-1","article-title":"Oral insulin delivery","volume":"35","author":"Carino","year":"1999","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2013.07.011_bb0010","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejpb.2012.07.014","article-title":"pH-sensitive polymeric nanoparticles to improve oral bioavailability of peptide\/protein drugs and poorly water-soluble drugs","volume":"82","author":"Wang","year":"2012","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nano.2013.07.011_bb0015","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jconrel.2003.12.022","article-title":"Oral insulin delivery using P(MAA-g-EG) hydrogels: effects of network morphology on insulin delivery characteristics","volume":"95","author":"Nakamura","year":"2004","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2013.07.011_bb0020","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejpb.2010.07.002","article-title":"Microemulsions for oral delivery of insulin: design, development and evaluation in streptozotocin induced diabetic rats","volume":"76","author":"Sharma","year":"2010","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nano.2013.07.011_bb0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejpb.2010.09.016","article-title":"Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin","volume":"77","author":"Zhang","year":"2011","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nano.2013.07.011_bb0030","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s00125-001-0751-z","article-title":"Self-assembled \u201cnanocubicle\" as a carrier for peroral insulin delivery","volume":"45","author":"Chung","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/j.nano.2013.07.011_bb0035","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1021\/bc100093v","article-title":"A novel approach to oral delivery of insulin by conjugating with low molecular weight chitosan","volume":"21","author":"Lee","year":"2010","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nano.2013.07.011_bb0040","doi-asserted-by":"crossref","first-page":"9826","DOI":"10.1016\/j.biomaterials.2011.08.087","article-title":"A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery","volume":"32","author":"Chen","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2013.07.011_bb0045","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0378-5173(01)00579-8","article-title":"Liposomes with phosphatidylethanol as a carrier for oral delivery of insulin: studies in the rat","volume":"216","author":"Kisel","year":"2001","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2013.07.011_bb0050","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ijpharm.2005.01.018","article-title":"Investigation of lectin-modified insulin liposomes as carriers for oral administration","volume":"294","author":"Zhang","year":"2005","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2013.07.011_bb0055","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ejpb.2010.12.008","article-title":"In vitro and in vivo evaluation of WGA-carbopol modified liposomes as carriers for oral peptide delivery","volume":"77","author":"Makhlof","year":"2011","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nano.2013.07.011_bb0060","first-page":"1155","article-title":"Liposomes containing glycocholate as potential oral insulin delivery systems: preparation, in vitro characterization, and improved protection against enzymatic degradation","volume":"6","author":"Niu","year":"2011","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2013.07.011_bb0065","first-page":"966","article-title":"Hypoglycemic efficacy of chitosan-coated insulin liposomes after oral administration in mice","volume":"25","author":"Wu","year":"2004","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.nano.2013.07.011_bb0070","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ijpharm.2008.11.013","article-title":"Chitosan-aprotinin coated liposomes for oral peptide delivery: development, characterisation and in vivo evaluation","volume":"370","author":"Takeuchi","year":"2009","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2013.07.011_bb0075","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1081\/DDC-120021771","article-title":"Double liposomes: hypoglycemic effects of liposomal insulin on normal rats","volume":"29","author":"Katayama","year":"2003","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.nano.2013.07.011_bb0080","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0168-3659(99)00146-7","article-title":"DepoFoam (TM) technology: a vehicle for controlled delivery of protein and peptide drugs","volume":"64","author":"Ye","year":"2000","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2013.07.011_bb0085","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/117739280700200003","article-title":"Targeting receptors, transporters and site of absorption to improve oral drug delivery","volume":"2","author":"Hamman","year":"2007","journal-title":"Drug Target Insights."},{"key":"10.1016\/j.nano.2013.07.011_bb0090","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1023\/A:1011908128045","article-title":"Recent advances in intestinal macromolecular drug delivery via receptor-mediated transport pathways","volume":"15","author":"Swaan","year":"1998","journal-title":"Pharm Res"},{"key":"10.1016\/j.nano.2013.07.011_bb0095","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/10611860410001693760","article-title":"Use of targeting agents to increase uptake and localization of drugs to the intestinal epithelium","volume":"12","author":"Russell-Jones","year":"2004","journal-title":"J Drug Target"},{"key":"10.1016\/j.nano.2013.07.011_bb0100","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1211\/jpp.61.04.0005","article-title":"Oral bioavailability enhancement of a hydrophilic drug delivered via folic acid-coupled liposomes in rats","volume":"61","author":"Ling","year":"2009","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.nano.2013.07.011_bb0105","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jconrel.2007.05.019","article-title":"Effective oral delivery of insulin in animal models using vitamin B12-coated dextran nanoparticles","volume":"122","author":"Chalasani","year":"2007","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2013.07.011_bb0110","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jconrel.2006.12.003","article-title":"A novel vitamin B12-nanosphere conjugate carrier system for peroral delivery of insulin","volume":"117","author":"Chalasani","year":"2007","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2013.07.011_bb0115","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1021\/bc700292v","article-title":"Preparation, characterization, and application of biotinylated and biotin-PEGylated glucagon-like peptide-1 analogues for enhanced oral delivery","volume":"19","author":"Chae","year":"2008","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nano.2013.07.011_bb0120","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/anie.200800865","article-title":"Traveling the vitamin B12 pathway: oral delivery of protein and peptide drugs","volume":"48","author":"Petrus","year":"2009","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.nano.2013.07.011_bb0125","doi-asserted-by":"crossref","first-page":"C605","DOI":"10.1152\/ajpcell.1999.277.4.C605","article-title":"Molecular mechanism of the intestinal biotin transport process","volume":"277","author":"Chatterjee","year":"1999","journal-title":"Am J Physiol-Cell Ph."},{"key":"10.1016\/j.nano.2013.07.011_bb0130","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ejpb.2007.07.009","article-title":"Improved peroral delivery of glucagon-like peptide-1 by site-specific biotin modification: design, preparation, and biological evaluation","volume":"68","author":"Youn","year":"2008","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nano.2013.07.011_bb0135","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1080\/10611860701350099","article-title":"Targeting of biotinylated oligonucleotides to prostate tumors with antibody-based delivery vehicles","volume":"15","author":"Mirochnik","year":"2007","journal-title":"J Drug Target"},{"key":"10.1016\/j.nano.2013.07.011_bb0140","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1021\/bc100054c","article-title":"Targeted cellular delivery of quantum dots loaded on and in biotinylated liposomes","volume":"21","author":"Sigot","year":"2010","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nano.2013.07.011_bb0145","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ijpharm.2012.01.034","article-title":"Synthesis and evaluation of biotin-conjugated pH-responsive polymeric micelles as drug carriers","volume":"427","author":"Kim","year":"2012","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2013.07.011_bb0150","first-page":"897","article-title":"Biotinylated PAMAM dendrimers for intracellular delivery of cisplatin to ovarian cancer: role of SMVT","volume":"31","author":"Yellepeddi","year":"2011","journal-title":"Anticancer Res"},{"key":"10.1016\/j.nano.2013.07.011_bb0155","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/03639045.2012.668912","article-title":"Influence of lipid composition on the phase transition temperature of liposomes composed of both DPPC and HSPC","volume":"39","author":"Chen","year":"2013","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.nano.2013.07.011_bb0160","first-page":"23","article-title":"Nanoemulsions coated with alginate\/chitosan as oral insulin delivery systems: preparation, characterization, and hypoglycemic effect in rats","volume":"8","author":"Li","year":"2013","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2013.07.011_bb0165","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejpb.2012.02.009","article-title":"Hypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: the effect of cholate type, particle size and administered dose","volume":"81","author":"Niu","year":"2012","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nano.2013.07.011_bb0170","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.2217\/nnm.12.31","article-title":"Folate-decorated PLGA nanoparticles as a rationally designed vehicle for the oral delivery of insulin","volume":"7","author":"Jain","year":"2012","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2013.07.011_bb0175","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1517\/17425247.5.6.693","article-title":"M cell-targeted delivery of vaccines and therapeutics","volume":"5","author":"Kuolee","year":"2008","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.nano.2013.07.011_bb0180","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.1021\/nn201009w","article-title":"Short ligands affect modes of QD uptake and elimination in human cells","volume":"5","author":"Al-Hajaj","year":"2011","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2013.07.011_bb0185","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.biomaterials.2012.10.003","article-title":"Transferrin receptor specific nanocarriers conjugated with functional 7peptide for oral drug delivery","volume":"34","author":"Du","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2013.07.011_bb0190","first-page":"15","article-title":"Pharmacological inhibition of endocytic pathways: is it specific enough to be useful?","volume":"Vol 440","author":"Ivanov","year":"2008"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963413003511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963413003511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T15:06:42Z","timestamp":1727795202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963413003511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S1549963413003511"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2013.07.011","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biotinylated liposomes as potential carriers for the oral delivery of insulin","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2013.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}